Stockreport

Institutional owners may consider drastic measures as Relay Therapeutics, Inc.'s (NASDAQ:RLAY) recent US$67m drop adds to long-term losses [Yahoo! Finance]

Relay Therapeutics, Inc.  (RLAY) 
PDF 50% of the business is held by the top 9 shareholders Insiders have been selling lately To get a sense of who is truly in control of Relay Therapeutics, Inc. ( NASD [Read more]